Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

J Natl Compr Canc Netw. 2018 Jul;16(7):852-871. doi: 10.6004/jnccn.2018.0060.

Abstract

The NCCN Guidelines for Anal Carcinoma provide recommendations for the management of patients with squamous cell carcinoma of the anal canal or perianal region. Primary treatment of anal cancer usually includes chemoradiation, although certain lesions can be treated with margin-negative local excision alone. Disease surveillance is recommended for all patients with anal carcinoma because additional curative-intent treatment is possible. A multidisciplinary approach including physicians from gastroenterology, medical oncology, surgical oncology, radiation oncology, and radiology is essential for optimal patient care.

Publication types

  • Practice Guideline

MeSH terms

  • Anal Canal / pathology
  • Anal Canal / surgery
  • Antineoplastic Combined Chemotherapy Protocols / standards
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Anus Neoplasms / diagnosis
  • Anus Neoplasms / epidemiology
  • Anus Neoplasms / pathology
  • Anus Neoplasms / therapy*
  • Biopsy
  • Carcinoma, Squamous Cell / diagnosis
  • Carcinoma, Squamous Cell / epidemiology
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / therapy*
  • Chemoradiotherapy / methods
  • Chemoradiotherapy / standards
  • Colostomy / standards
  • Disease-Free Survival
  • Humans
  • Medical Oncology / standards*
  • Neoplasm Recurrence, Local / diagnosis
  • Neoplasm Recurrence, Local / epidemiology
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Recurrence, Local / therapy*
  • Patient Care Team / standards
  • Randomized Controlled Trials as Topic
  • Societies, Medical / standards*
  • United States / epidemiology

Supplementary concepts

  • Anal Canal Carcinoma